CN118215669A - 异野漆树苷及其衍生物用于促进神经修复的用途 - Google Patents
异野漆树苷及其衍生物用于促进神经修复的用途 Download PDFInfo
- Publication number
- CN118215669A CN118215669A CN202280071472.9A CN202280071472A CN118215669A CN 118215669 A CN118215669 A CN 118215669A CN 202280071472 A CN202280071472 A CN 202280071472A CN 118215669 A CN118215669 A CN 118215669A
- Authority
- CN
- China
- Prior art keywords
- nerve
- isorhoifolin
- brain
- derivatives
- injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271411P | 2021-10-25 | 2021-10-25 | |
| US63/271,411 | 2021-10-25 | ||
| PCT/CN2022/127372 WO2023072069A1 (zh) | 2021-10-25 | 2022-10-25 | 异野漆树苷及其衍生物用于促进神经修复的用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118215669A true CN118215669A (zh) | 2024-06-18 |
Family
ID=86159046
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280071472.9A Pending CN118215669A (zh) | 2021-10-25 | 2022-10-25 | 异野漆树苷及其衍生物用于促进神经修复的用途 |
| CN202280071353.3A Pending CN118139869A (zh) | 2021-10-25 | 2022-10-25 | 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280071353.3A Pending CN118139869A (zh) | 2021-10-25 | 2022-10-25 | 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20240415859A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4424695A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2024539499A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20240090982A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118215669A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI898161B (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023072085A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045072A (zh) * | 2007-05-08 | 2007-10-03 | 胡军 | 山香圆叶提取物及其医药用途 |
| CN102617659A (zh) * | 2012-03-09 | 2012-08-01 | 中国烟草总公司郑州烟草研究院 | α-紫罗兰醇葡糖苷的合成方法及其在卷烟中的加香应用 |
| CN102617658B (zh) * | 2012-03-09 | 2014-08-20 | 中国烟草总公司郑州烟草研究院 | β-紫罗兰醇-β-D-葡糖苷的制备方法及其在烟草加香中的应用 |
| CN106167508A (zh) * | 2016-07-13 | 2016-11-30 | 上海应用技术学院 | 一种具有紫罗兰香味的葡萄糖苷化合物及其制备方法 |
-
2022
- 2022-10-25 JP JP2024547815A patent/JP2024539499A/ja active Pending
- 2022-10-25 CN CN202280071472.9A patent/CN118215669A/zh active Pending
- 2022-10-25 EP EP22885946.8A patent/EP4424695A4/en active Pending
- 2022-10-25 WO PCT/CN2022/127414 patent/WO2023072085A1/zh not_active Ceased
- 2022-10-25 KR KR1020247017445A patent/KR20240090982A/ko active Pending
- 2022-10-25 WO PCT/CN2022/127372 patent/WO2023072069A1/zh not_active Ceased
- 2022-10-25 US US18/704,869 patent/US20240415859A1/en active Pending
- 2022-10-25 CN CN202280071353.3A patent/CN118139869A/zh active Pending
- 2022-10-25 EP EP22885962.5A patent/EP4424694A4/en active Pending
- 2022-10-25 US US18/704,860 patent/US20250255893A1/en active Pending
- 2022-10-25 TW TW111140498A patent/TWI898161B/zh active
- 2022-10-25 JP JP2024547816A patent/JP2024541121A/ja active Pending
- 2022-10-25 KR KR1020247017446A patent/KR20240090983A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024541121A (ja) | 2024-11-06 |
| US20240415859A1 (en) | 2024-12-19 |
| TW202320806A (zh) | 2023-06-01 |
| KR20240090983A (ko) | 2024-06-21 |
| KR20240090982A (ko) | 2024-06-21 |
| EP4424694A1 (en) | 2024-09-04 |
| TWI898161B (zh) | 2025-09-21 |
| WO2023072069A1 (zh) | 2023-05-04 |
| US20250255893A1 (en) | 2025-08-14 |
| CN118139869A (zh) | 2024-06-04 |
| TW202317142A (zh) | 2023-05-01 |
| EP4424695A4 (en) | 2025-10-22 |
| EP4424695A1 (en) | 2024-09-04 |
| WO2023072085A1 (zh) | 2023-05-04 |
| JP2024539499A (ja) | 2024-10-28 |
| EP4424694A4 (en) | 2026-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106795490B (zh) | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 | |
| Thanos et al. | Traumatology of the optic nerve and contribution of crystallins to axonal regeneration | |
| CN120699131B (zh) | 治疗帕金森病的化学遗传学基因治疗新方案 | |
| Stepanova et al. | Isolation of rat olfactory ensheathing cells and their use in the therapy of posttraumatic cysts of the spinal cord | |
| Lepore | Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury | |
| Parvin et al. | Effects of artemisinin and TSP‑1‑human endometrial‑derived stem cells on a streptozocin‑induced model of Alzheimer’s disease and diabetes in Wistar rats | |
| TWI898161B (zh) | 異野漆樹苷及其衍生物用於促進神經修復的用途 | |
| Anoop et al. | A New Technique and Device for Controlled and Continuous Drug Delivery into the Brain–A Proof of Concept Study | |
| Voronova et al. | Survival and migration of rat olfactory ensheathing cells after transplantation into posttraumatic cysts in the spinal cord | |
| CN117838730A (zh) | 一种神经干细胞外囊泡在制备治疗脑出血继发性损伤的药物中的应用及药物组合物 | |
| RU2129427C1 (ru) | Способ лечения заболеваний центральной нервной системы | |
| RU2206299C2 (ru) | Способ лечения заболеваний зрительного анализатора | |
| JP2024539499A5 (cg-RX-API-DMAC7.html) | ||
| RU2375022C1 (ru) | Способ лечения атрофии зрительного нерва различной этиологии | |
| Cheng et al. | Rag1−/− mice with T and B lymphocyte deficiency exhibit milder retinal inflammatory response and retinal ganglion cell injury after optic nerve crush | |
| Shkap et al. | Fate of Transplanted Allogeneic Mesenchymal Stromal Cells in the Rat Spinal Cord under Normal Conditions and during the Acute Phase of Spinal Cord Contusion Injury | |
| TWI823110B (zh) | 天南星科萃取物用於促進神經修復的用途 | |
| Hwang et al. | Stem cells ameliorate neurotrauma-induced visual disturbances and retinopathy via broad normalization of the β-catenin-related signaling pathway | |
| CN120617308A (zh) | CD8α阳性巨噬细胞在视神经损伤治疗中的应用 | |
| WO2023202682A1 (zh) | 治疗或诊断情绪障碍或应激障碍的新靶点和其应用 | |
| Hesse | 11 Surgical Treatments | |
| CN115944713A (zh) | 一种神经营养因子和穿透肽组合物及其应用 | |
| JP2024541121A5 (cg-RX-API-DMAC7.html) | ||
| CN119454962A (zh) | 神经颗粒素抑制剂在制备治疗神经损伤相关疾病的药物中的应用 | |
| MCCORD | THE GLANDS OF INTERNAL SECRETION AND THEIR IMPORTANCE AS THERAPEUTIC |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |